Product Name

  • Name

    Nelfinavir

  • EINECS 1533716-785-6
  • CAS No. 159989-64-7
  • Article Data12
  • CAS DataBase
  • Density 1.226 g/cm3
  • Solubility 7g/L(temperature not stated)
  • Melting Point 185-186 °C
  • Formula C32H45N3O4S
  • Boiling Point 786.839 °C at 760 mmHg
  • Molecular Weight 567.793
  • Flash Point 429.665 °C
  • Transport Information
  • Appearance white to off-white crystalline powder
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 159989-64-7 (Nelfinavir)
  • Hazard Symbols
  • Synonyms 3-Isoquinolinecarboxamide,N-(1,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-,[3S-[2(2S*,3S*),3a,4ab,8ab]]-;AG 1341;(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboxamide;
  • PSA 189.95000
  • LogP 6.05210

Synthetic route

thiophenol
108-98-5

thiophenol

(3S,4aS,8aS)-N-tert-butyl-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)-decahydroisoquinoline-3-carboxamide
188936-07-4

(3S,4aS,8aS)-N-tert-butyl-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)-decahydroisoquinoline-3-carboxamide

A

nelfinavir
159989-64-7

nelfinavir

B

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide
1025935-06-1

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide

Conditions
ConditionsYield
With potassium hydrogencarbonate In various solvent(s) at 115℃; for 4h;A 84%
B 8 % Chromat.
With triethylamine In N,N-dimethyl-formamide at 80℃; for 10h; Product distribution; other base, other temperature, other solvents;A 84 % Chromat.
B 16 % Chromat.
In ethylene glycol at 120℃; for 20h;A 18 % Chromat.
B 82 % Chromat.
thiophenol
108-98-5

thiophenol

(3S,4aS,8aS)-N-tert-butyl-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)-decahydroisoquinoline-3-carboxamide
188936-07-4

(3S,4aS,8aS)-N-tert-butyl-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)-decahydroisoquinoline-3-carboxamide

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
82%
With potassium hydrogencarbonate at 140℃; for 5h; Sealed tube;78%
With potassium hydrogencarbonate In various solvent(s) Substitution;72%
With triethylamine In water; N,N-dimethyl-formamide; toluene; butanone65%
3-acetoxy-2-methylbenzoyl chloride
167678-46-8

3-acetoxy-2-methylbenzoyl chloride

(2R,3R)-4-((3S,4aS,8aS)-3-(tertbutylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-aminium benzoate

(2R,3R)-4-((3S,4aS,8aS)-3-(tertbutylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-aminium benzoate

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Stage #1: 3-acetoxy-2-methylbenzoyl chloride; (2R,3R)-4-((3S,4aS,8aS)-3-(tertbutylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-aminium benzoate In ethanol
Stage #2: With sodium hydroxide
79%
active charcoal

active charcoal

thiophenol
108-98-5

thiophenol

butanone
78-93-3

butanone

(3S,4aS,8aS)-N-tert-butyl-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)-decahydroisoquinoline-3-carboxamide
188936-07-4

(3S,4aS,8aS)-N-tert-butyl-2-((R)-2-hydroxy-2-((S)-2-(3-hydroxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)ethyl)-decahydroisoquinoline-3-carboxamide

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
In pyridine69%
(3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide
128019-40-9, 149510-73-6, 136465-81-1

(3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide

Acetic acid 3-((1R,2S)-2,3-dihydroxy-1-phenylsulfanylmethyl-propylcarbamoyl)-2-methyl-phenyl ester
767341-27-5

Acetic acid 3-((1R,2S)-2,3-dihydroxy-1-phenylsulfanylmethyl-propylcarbamoyl)-2-methyl-phenyl ester

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Stage #1: Acetic acid 3-((1R,2S)-2,3-dihydroxy-1-phenylsulfanylmethyl-propylcarbamoyl)-2-methyl-phenyl ester With triethylamine; p-toluenesulfonyl chloride
Stage #2: (3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide
59%
(3S,4AS,8AS)-2-[(2R,3R)-3-(3-acetoxy-2-methylbenzoylamino)-2-hydroxy-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide

(3S,4AS,8AS)-2-[(2R,3R)-3-(3-acetoxy-2-methylbenzoylamino)-2-hydroxy-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
With ammonia; water In methanol at 20℃; for 1.5h;54%
With ammonia; water In methanol at 20℃; for 3h; Inert atmosphere;884 mg
Stage #1: (3S,4AS,8AS)-2-[(2R,3R)-3-(3-acetoxy-2-methylbenzoylamino)-2-hydroxy-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide With sodium hydroxide; water; benzyl alcohol at 20 - 82℃; for 0.583333h; pH=14;
Stage #2: With water; acetic acid In benzyl alcohol at 53℃; pH=7 - 7.5; Product distribution / selectivity;
(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-4-hydroxybutan-2-yl-4-methoxybenzoate

(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-4-hydroxybutan-2-yl-4-methoxybenzoate

thiophenol
108-98-5

thiophenol

A

nelfinavir
159989-64-7

nelfinavir

B

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide
1025935-06-1

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide

Conditions
ConditionsYield
Stage #1: (2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-4-hydroxybutan-2-yl-4-methoxybenzoate With methanesulfonyl chloride; triethylamine In N,N-dimethyl-formamide at 20℃;
Stage #2: thiophenol at 120℃;
Stage #3: With potassium carbonate In methanol at 40℃;
A 31%
B 41%
3-acetoxy-2-methylbenzoic acid
168899-58-9

3-acetoxy-2-methylbenzoic acid

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 72 percent / EDCI; HOBt
2: 100 percent / HCl / methanol / 3 h / 40 °C
3: 59 percent / TsCl; Et3N
View Scheme
1-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-2-phenylsulfanyl-ethylamine

1-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-2-phenylsulfanyl-ethylamine

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 72 percent / EDCI; HOBt
2: 100 percent / HCl / methanol / 3 h / 40 °C
3: 59 percent / TsCl; Et3N
View Scheme
2-Benzenesulfinyl-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethylamine

2-Benzenesulfinyl-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethylamine

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 71 percent / BF3*Et2O; NaI
2: 72 percent / EDCI; HOBt
3: 100 percent / HCl / methanol / 3 h / 40 °C
4: 59 percent / TsCl; Et3N
View Scheme
Acetic acid 3-[(R)-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-phenylsulfanyl-ethylcarbamoyl]-2-methyl-phenyl ester
767341-31-1

Acetic acid 3-[(R)-1-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-phenylsulfanyl-ethylcarbamoyl]-2-methyl-phenyl ester

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 100 percent / HCl / methanol / 3 h / 40 °C
2: 59 percent / TsCl; Et3N
View Scheme
(3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide
128019-40-9, 149510-73-6, 136465-81-1

(3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3 / propan-2-ol / Heating
View Scheme
Multi-step reaction with 2 steps
1: K2CO3 / methanol; H2O / 5 h / 50 °C
2: 72 percent / KHCO3 / various solvent(s)
View Scheme
Multi-step reaction with 7 steps
1.1: sodium carbonate / N,N-dimethyl-formamide / 30 h / 120 °C
2.1: hydrogenchloride / tetrahydrofuran; water / 3.5 h / 20 °C
3.1: triethylamine / dichloromethane / 0.5 h / 0 - 20 °C
4.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
4.2: 3 h / -78 - 0 °C
5.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 0.33 h / 20 °C
5.2: 3 h / 50 °C
6.1: potassium carbonate / methanol / 2 h / 100 °C / Sealed tube
7.1: potassium hydrogencarbonate / 5 h / 140 °C / Sealed tube
View Scheme
Acetic acid 3-{(S)-4-[(S)-1-hydroxy-2-(toluene-4-sulfonyloxy)-ethyl]-4,5-dihydro-oxazol-2-yl}-2-methyl-phenyl ester
201402-95-1

Acetic acid 3-{(S)-4-[(S)-1-hydroxy-2-(toluene-4-sulfonyloxy)-ethyl]-4,5-dihydro-oxazol-2-yl}-2-methyl-phenyl ester

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3 / propan-2-ol / Heating
View Scheme
3-acetoxy-2-methylbenzoyl chloride
167678-46-8

3-acetoxy-2-methylbenzoyl chloride

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: Et3N / ethyl acetate / 1.75 h / 20 °C
1.2: H2SO4 (98 percent) / ethyl acetate / 17 h / 20 °C
2.1: K2CO3 / methanol; H2O / 5 h / 50 °C
3.1: 72 percent / KHCO3 / various solvent(s)
View Scheme
Multi-step reaction with 5 steps
1: NaHCO3 / CH2Cl2; H2O
2: Et3N / CH2Cl2
3: 1.) BF3*Et2O / 1.) CH2Cl2
4: K2CO3 / methanol; H2O
5: 18 percent Chromat. / ethane-1,2-diol / 20 h / 120 °C
View Scheme
(2R)-1-acetoxy-2-((4S)-2-(3-acetoxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)-2-methanesulfonyloxyethane
188936-06-3

(2R)-1-acetoxy-2-((4S)-2-(3-acetoxy-2-methylphenyl)-4,5-dihydrooxazol-4-yl)-2-methanesulfonyloxyethane

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: K2CO3 / methanol; H2O / 5 h / 50 °C
2: 72 percent / KHCO3 / various solvent(s)
View Scheme
Multi-step reaction with 2 steps
1: K2CO3 / methanol; H2O
2: 18 percent Chromat. / ethane-1,2-diol / 20 h / 120 °C
View Scheme
Acetic acid 3-((5S,6R)-6-hydroxy-2,2-dimethyl-[1,3]dioxepan-5-ylcarbamoyl)-2-methyl-phenyl ester
188936-02-9

Acetic acid 3-((5S,6R)-6-hydroxy-2,2-dimethyl-[1,3]dioxepan-5-ylcarbamoyl)-2-methyl-phenyl ester

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Et3N / CH2Cl2
2: 1.) BF3*Et2O / 1.) CH2Cl2
3: K2CO3 / methanol; H2O
4: 18 percent Chromat. / ethane-1,2-diol / 20 h / 120 °C
View Scheme
Acetic acid 3-((5S,6R)-6-methanesulfonyloxy-2,2-dimethyl-[1,3]dioxepan-5-ylcarbamoyl)-2-methyl-phenyl ester
188936-03-0

Acetic acid 3-((5S,6R)-6-methanesulfonyloxy-2,2-dimethyl-[1,3]dioxepan-5-ylcarbamoyl)-2-methyl-phenyl ester

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) BF3*Et2O / 1.) CH2Cl2
2: K2CO3 / methanol; H2O
3: 18 percent Chromat. / ethane-1,2-diol / 20 h / 120 °C
View Scheme
3-acetoxy-2-methylbenzoyl chloride
167678-46-8

3-acetoxy-2-methylbenzoyl chloride

(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-3-benzyloxycarbonylamino-2-hydroxy-4-(phenylthio)butyl]decahydroisoquinoline-3-carboxamide
159878-04-3

(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-3-benzyloxycarbonylamino-2-hydroxy-4-(phenylthio)butyl]decahydroisoquinoline-3-carboxamide

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Stage #1: (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-3-benzyloxycarbonylamino-2-hydroxy-4-(phenylthio)butyl]decahydroisoquinoline-3-carboxamide Alkaline aqueous solution; Heating / reflux;
Stage #2: 3-acetoxy-2-methylbenzoyl chloride In water Alkaline aqueous solution;
3-hydroxy 2-methylbenzoic acid
603-80-5

3-hydroxy 2-methylbenzoic acid

(2R,3R)-4-((3S,4aS,8aS)-3-(tertbutylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-aminium benzoate

(2R,3R)-4-((3S,4aS,8aS)-3-(tertbutylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-aminium benzoate

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Stage #1: 3-hydroxy 2-methylbenzoic acid; (2R,3R)-4-((3S,4aS,8aS)-3-(tertbutylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-aminium benzoate In methanol
Stage #2: With sodium hydroxide
(3S,4aS,8aS)-N-tert-butyl-2-(((4S,5R)-2-(4-methoxyphenyl)-4-vinyl-4,5-dihydrooxazol-5-yl)methyl)decahydroisoquinoline-3-carboxamide

(3S,4aS,8aS)-N-tert-butyl-2-(((4S,5R)-2-(4-methoxyphenyl)-4-vinyl-4,5-dihydrooxazol-5-yl)methyl)decahydroisoquinoline-3-carboxamide

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: hydrogenchloride / tetrahydrofuran; water / 3.5 h / 20 °C
2.1: triethylamine / dichloromethane / 0.5 h / 0 - 20 °C
3.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
3.2: 3 h / -78 - 0 °C
4.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 0.33 h / 20 °C
4.2: 3 h / 50 °C
5.1: potassium carbonate / methanol / 2 h / 100 °C / Sealed tube
6.1: potassium hydrogencarbonate / 5 h / 140 °C / Sealed tube
View Scheme
(3S,4aS,8aS)-N-tert-butyl-2-(((4S,5R)-2-(4-methoxyphenyl)-4-vinyl-4,5-dihydrooxazol-5-yl)methyl)decahydroisoquinoline-3-carboxamide

(3S,4aS,8aS)-N-tert-butyl-2-(((4S,5R)-2-(4-methoxyphenyl)-4-vinyl-4,5-dihydrooxazol-5-yl)methyl)decahydroisoquinoline-3-carboxamide

A

nelfinavir
159989-64-7

nelfinavir

B

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide
1025935-06-1

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: hydrogenchloride / tetrahydrofuran; water / 3.5 h / 20 °C
2.1: triethylamine / dichloromethane / 0.5 h / 0 - 20 °C
3.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
3.2: 3 h / -78 - 0 °C
4.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 20 °C
4.2: 120 °C
4.3: 40 °C
View Scheme
(3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide
128019-40-9, 149510-73-6, 136465-81-1

(3S,4aS,8aS)-N-tert-butyl-decahydroisoquinoline-3-carboxamide

A

nelfinavir
159989-64-7

nelfinavir

B

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide
1025935-06-1

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: sodium carbonate / N,N-dimethyl-formamide / 30 h / 120 °C
2.1: hydrogenchloride / tetrahydrofuran; water / 3.5 h / 20 °C
3.1: triethylamine / dichloromethane / 0.5 h / 0 - 20 °C
4.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
4.2: 3 h / -78 - 0 °C
5.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 20 °C
5.2: 120 °C
5.3: 40 °C
View Scheme
(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)pent-4-en-2-yl-4-methoxybenzoate

(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)pent-4-en-2-yl-4-methoxybenzoate

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
1.2: 3 h / -78 - 0 °C
2.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 0.33 h / 20 °C
2.2: 3 h / 50 °C
3.1: potassium carbonate / methanol / 2 h / 100 °C / Sealed tube
4.1: potassium hydrogencarbonate / 5 h / 140 °C / Sealed tube
View Scheme
(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)pent-4-en-2-yl-4-methoxybenzoate

(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)pent-4-en-2-yl-4-methoxybenzoate

A

nelfinavir
159989-64-7

nelfinavir

B

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide
1025935-06-1

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
1.2: 3 h / -78 - 0 °C
2.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 20 °C
2.2: 120 °C
2.3: 40 °C
View Scheme
C27H41N3O4

C27H41N3O4

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: triethylamine / dichloromethane / 0.5 h / 0 - 20 °C
2.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
2.2: 3 h / -78 - 0 °C
3.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 0.33 h / 20 °C
3.2: 3 h / 50 °C
4.1: potassium carbonate / methanol / 2 h / 100 °C / Sealed tube
5.1: potassium hydrogencarbonate / 5 h / 140 °C / Sealed tube
View Scheme
C27H41N3O4

C27H41N3O4

A

nelfinavir
159989-64-7

nelfinavir

B

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide
1025935-06-1

(3S,4aS,8aS)-2-[(2S,3S)-3-Hydroxy-2-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: triethylamine / dichloromethane / 0.5 h / 0 - 20 °C
2.1: hydrogenchloride; ozone; oxygen / dichloromethane; ethyl acetate / 0.58 h / -78 °C
2.2: 3 h / -78 - 0 °C
3.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 20 °C
3.2: 120 °C
3.3: 40 °C
View Scheme
(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-4-hydroxybutan-2-yl-4-methoxybenzoate

(2R,3S)-3-(3-acetoxy-2-methylbenzamido)-1-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-4-hydroxybutan-2-yl-4-methoxybenzoate

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: triethylamine; methanesulfonyl chloride / N,N-dimethyl-formamide / 0.33 h / 20 °C
1.2: 3 h / 50 °C
2.1: potassium carbonate / methanol / 2 h / 100 °C / Sealed tube
3.1: potassium hydrogencarbonate / 5 h / 140 °C / Sealed tube
View Scheme
C36H47N3O7

C36H47N3O7

nelfinavir
159989-64-7

nelfinavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / methanol / 2 h / 100 °C / Sealed tube
2: potassium hydrogencarbonate / 5 h / 140 °C / Sealed tube
View Scheme
methanesulfonic acid
75-75-2

methanesulfonic acid

nelfinavir
159989-64-7

nelfinavir

nelfinavir mesylate
159989-65-8

nelfinavir mesylate

Conditions
ConditionsYield
In acetone at 20 - 35℃; for 2h; Product distribution / selectivity;98%
Stage #1: methanesulfonic acid; nelfinavir In methanol at 25 - 30℃; for 0.166667h;
Stage #2: In methanol at 25 - 30℃; for 0.25h; Carbon;
Stage #3: at 40 - 55℃; under 10 - 150 Torr; for 1h; Product distribution / selectivity;
92%
In ethanol Product distribution / selectivity;80%
methyltertbutyl ether
67000-01-5

methyltertbutyl ether

nelfinavir
159989-64-7

nelfinavir

nelfinavir mesylate
159989-65-8

nelfinavir mesylate

Conditions
ConditionsYield
With methanesulfonic acid In tetrahydrofuran95%
nelfinavir
159989-64-7

nelfinavir

1,2:5,6-di-O-isopropylidene-3-O-(4-izocyanatobutyl)-α-D-glucofuranose

1,2:5,6-di-O-isopropylidene-3-O-(4-izocyanatobutyl)-α-D-glucofuranose

[4-[3-O-(1,2:5,6-di-O-isopropylidene-α-D-glucofuranose)]-butyl]carbamic acid 1(R)-[3(S)-tert-butylcarbamoyloctahydro-4a(S),8a(S)-isoquinolin-2-ylmethyl]-2(S)-(3-hydroxy-2-methylbenzoylamino)-3-phenylsulfanylpropyl ester

[4-[3-O-(1,2:5,6-di-O-isopropylidene-α-D-glucofuranose)]-butyl]carbamic acid 1(R)-[3(S)-tert-butylcarbamoyloctahydro-4a(S),8a(S)-isoquinolin-2-ylmethyl]-2(S)-(3-hydroxy-2-methylbenzoylamino)-3-phenylsulfanylpropyl ester

Conditions
ConditionsYield
With copper(l) chloride In dichloromethane; N,N-dimethyl-formamide at 20℃;63.5%
C22H30N6O4S2

C22H30N6O4S2

nelfinavir
159989-64-7

nelfinavir

A

C54H73N9O7S3

C54H73N9O7S3

B

C54H73N9O7S3

C54H73N9O7S3

C

C76H101N15O10S5

C76H101N15O10S5

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere; Molecular sieve;A 62%
B 3%
C 2%
nelfinavir
159989-64-7

nelfinavir

1,2:5,6-di-O-isopropylidene-3-O-(3-carboxypropanoyl)-α-D-glucofuranose

1,2:5,6-di-O-isopropylidene-3-O-(3-carboxypropanoyl)-α-D-glucofuranose

succinic acid 3-[3-[3(S)-tert-butylcarbamoyloctahydro-4a(S),8a(S)-isoquinolin-2-yl]-2(R)-hydroxy-1(S)-phenylsulfanylmethylpropylcarbamoyl]-2-methylphenyl ester 4-[3-O-(1,2:5,6-di-O-isopropylidene-α-D-glucofuranose)] ester

succinic acid 3-[3-[3(S)-tert-butylcarbamoyloctahydro-4a(S),8a(S)-isoquinolin-2-yl]-2(R)-hydroxy-1(S)-phenylsulfanylmethylpropylcarbamoyl]-2-methylphenyl ester 4-[3-O-(1,2:5,6-di-O-isopropylidene-α-D-glucofuranose)] ester

Conditions
ConditionsYield
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0 - 20℃;16%
nelfinavir
159989-64-7

nelfinavir

[4-[3-O-D-glucose]-butyl]carbamic acid 1(R)-[3(S)-tert-butylcarbamoyloctahydro-4a(S),8a(S)-isoquinolin-2-ylmethyl]-2(S)-(3-hydroxy-2-methylbenzoylamino)-3-phenylsulfanylpropyl ester (bis trifluoroacatic acid salt)

[4-[3-O-D-glucose]-butyl]carbamic acid 1(R)-[3(S)-tert-butylcarbamoyloctahydro-4a(S),8a(S)-isoquinolin-2-ylmethyl]-2(S)-(3-hydroxy-2-methylbenzoylamino)-3-phenylsulfanylpropyl ester (bis trifluoroacatic acid salt)

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 63.5 percent / CuCl / CH2Cl2; dimethylformamide / 20 °C
2: 97 percent / H2O; acetonitrile / 0 - 20 °C
View Scheme
7-(3-benzyl-1-ethyl-(1H)-pyrazol-5-yl)-3-azabicyclo[3.3.0]octane

7-(3-benzyl-1-ethyl-(1H)-pyrazol-5-yl)-3-azabicyclo[3.3.0]octane

nelfinavir
159989-64-7

nelfinavir

1-(((3S,4S)-3-((7-(3-Benzyl-1-ethyl-(1H)-pyrazol-5-yl)-3-azabicyclo[3.3.0]octan-3-yl)methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl)methyl) cyclohexanecarboxylic Acid

1-(((3S,4S)-3-((7-(3-Benzyl-1-ethyl-(1H)-pyrazol-5-yl)-3-azabicyclo[3.3.0]octan-3-yl)methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl)methyl) cyclohexanecarboxylic Acid

nelfinavir
159989-64-7

nelfinavir

3-({3-[3-(tert-butylaminomethyl)octahydroisoquinolin-2-yl]-2-hydroxy-1-phenylsulfanylmethylpropylamino}methyl)-2-methylphenol

3-({3-[3-(tert-butylaminomethyl)octahydroisoquinolin-2-yl]-2-hydroxy-1-phenylsulfanylmethylpropylamino}methyl)-2-methylphenol

Conditions
ConditionsYield
Stage #1: nelfinavir With borane-THF In tetrahydrofuran at 65℃; Inert atmosphere;
Stage #2: With piperidine In methanol at 65℃; Inert atmosphere;

Nelfinavir Specification

The Nelfinavir, with the CAS registry number 159989-64-7, is also known as 3-Isoquinolinecarboxamide,N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-,(3S,4aS,8aS)-. This chemical's molecular formula is C32H45N3O4S and molecular weight is 567.79. What's more, its systematic name is (3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]-N-(2-methyl-2-propanyl)decahydro-3-isoquinolinecarboxamide. Its classification codes are: (1)Anti-HIV agents; (2)Anti-Infective Agents; (3)Anti-Retroviral Agents; (4)Antiviral Agents; (5)Enzyme Inhibitors; (6)HIV Protease inhibitors; (7)Protease Inhibitors. This chemical is a potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. It belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is generally used in combination with other antiretroviral drugs. 

Physical properties of Nelfinavir are: (1)ACD/LogP: 7.278; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 6.80; (4)ACD/LogD (pH 7.4): 7.26; (5)ACD/BCF (pH 5.5): 66657.38; (6)ACD/BCF (pH 7.4): 193716.50; (7)ACD/KOC (pH 5.5): 72239.41; (8)ACD/KOC (pH 7.4): 209938.70; (9)#H bond acceptors: 7; (10)#H bond donors: 4; (11)#Freely Rotating Bonds: 12; (12)Polar Surface Area: 127.2 Å2; (13)Index of Refraction: 1.619; (14)Molar Refractivity: 162.378 cm3; (15)Molar Volume: 463.136 cm3; (16)Polarizability: 64.372×10-24cm3; (17)Surface Tension: 58.72 dyne/cm; (18)Density: 1.226 g/cm3; (19)Flash Point: 429.665 °C; (20)Enthalpy of Vaporization: 120.056 kJ/mol; (21)Boiling Point: 786.839 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(c1cccc(O)c1C)N[C@@H](CSc2ccccc2)[C@H](O)CN4[C@H](C(=O)NC(C)(C)C)C[C@@H]3CCCC[C@@H]3C4
(2)Std. InChI: InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1
(3)Std. InChIKey: QAGYKUNXZHXKMR-HKWSIXNMSA-N

The toxicity data is as follows:  

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
rat LD oral > 5gm/kg (5000mg/kg)   Toxicologist. Vol. 42, Pg. 55, 1998.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View